The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)
Advanced Search

Session Details

Oral Presentation(E) Pharmaceutical Health Care and Sciences

[28-20-am]Pharmacotherapy (Oncology, Personalized, and Others)

Fri. Mar 28, 2025 3:00 PM - 4:36 PM JST
Fri. Mar 28, 2025 6:00 AM - 7:36 AM UTC
Room 20 (FUKUOKA SUNPALACE: Palace RoomB [2F])
Chair: Rintaro Sogawa, Junji Saruwatari
3:00 PM - 3:12 PM JST(6:00 AM - 6:12 AM UTC)

[28-20-pm09]Longitudinal Quality of Life Study of a Patient Participatory Medical Cooperation Support System in Hormone Therapy for Breast Cancer over a One-Year Period after Pilot Implementation

○Shinji Takayama1, Yuko Tanaka2, Risa Kasahara3, Reika In4, Yasue Tsuchida5, Seigo Nakamura5,3, Hideko Yamauchi6, Atsushi Yoshida3, Kazumi Goto1, Naoki Hayashi5,3 (1. Dep. Pharm., St. Luke's International Hospital, 2. Dep. Nurse., St. Luke's International Hospital, 3. Dep. Breast Surgical Oncology, St. Luke's International Hospital, 4. mammaira tsukiji mammaira tsukiji, 5. Division of Breast Surgical Oncology, Showa Univ., 6. University of Hawaii, Cancer Center)
3:12 PM - 3:24 PM JST(6:12 AM - 6:24 AM UTC)

[28-20-pm10]Impact of chemotherapy on the occurrence of obinutuzumab-induced infusion reaction in clinical practice: a single-center retrospective study

○Kaori Ito1,2,3, Tatsuya Ohtsubo4, Satoshi Dote5, Kaito Makio2, Maiko Mori2,3, Ｍisaki Morisaku2, Ｈidezo Matsuda2 (1. Fac. Pharm., Meijo Univ., 2. Dept. Pharm., Fujita Health Univ. Hos., 3. Dept. Hem., School of Med., Fujita Health Univ., 4. Dept. Pharm., Japanese Red Cross Kyoto Daini Hos., 5. Dept. Pharm., Kyoto-Katsura Hos.)
3:24 PM - 3:36 PM JST(6:24 AM - 6:36 AM UTC)

[28-20-pm11]Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients.

○Yuko Kanbayashi1, Eren Tsuchiya2, Tadashi Shimizu 3, Mayako Uchida4 (1. Osaka Med. Pharm. Univ., 2. Doshisha Women’s Coll. Liberal Arts, 3. Sch. Pharm., Hyogo Med. Univ., 4. Dept. Pharm., Kyushu Univ. Hosp.)
3:36 PM - 3:48 PM JST(6:36 AM - 6:48 AM UTC)

[28-20-pm12S]External validation of warfarin population kinetic-pharmacodynamic model for PT-INR

○Haruka Inoue1, Takahiko Aoyama1, Toshinori Hirai2, Yasuhiro Tsuji1 (1. Nihon Univ., 2. Institute of Science Tokyo Hospital, Department of Pharmacy)
3:48 PM - 4:00 PM JST(6:48 AM - 7:00 AM UTC)

[28-20-pm13]Assessment of Psychotropics and Antiepileptics Efficacy on the Management of AMPHs Dependence in Saudi Arabia: A Cross-sectional Study

○Abdullah Adnan Alhifany1 (1. Umm Al-Qura University College of Pharmacy)
4:00 PM - 4:12 PM JST(7:00 AM - 7:12 AM UTC)

[28-20-pm14S]Fundamental investigation for CYP2D6 activity prediction by quantifying dietary-derived markers

○Nagomi Hayashi1, Masaki Kumondai2, Yotaro Matsumoto1,2, Masamitsu Maekawa1,2, Yoshihisa Tomioka1,2, Nariyasu Mano1,2 (1. Grad. Sch. Pharm. Sci., Tohoku Univ., 2. Dept. Pharm. Sci., Tohoku Univ. Hosp.)
4:12 PM - 4:24 PM JST(7:12 AM - 7:24 AM UTC)

[28-20-pm15S]Functional changes in variant enzymes in CYP2D6 gene polymorphisms identified in large-scale Japanese genome analysis

○Shota Nishihara1, Eiji Hishinuma2,3, Caroline Kijogi1, Akiko Ueda2, Yuma Suzuki1, Yuki Ohmori1, Akihito Otsuki3, Noriko Ishida3, Masahiro Hiratsuka1,2,3,4 (1. Grad. Sch. Pharm. Sci., Tohoku Univ., 2. INGEM, Tohoku Univ., 3. ToMMo, Tohoku Univ., 4. Depart.k Pharm. Sci., Tohoku Univ. Hosp.)
4:24 PM - 4:36 PM JST(7:24 AM - 7:36 AM UTC)

[28-20-pm16S]Search for indicators of placental maturity based on changes in Human Placental Lactogen (hPL)

○Kanoko Okuba1, Miu Kato1, Minako Ohishi1, Ikeda Kenji1 (1. Grad.Sch.Pharm.Sci., Osaka Univ.)
Back to Category List